Alana Sine Appointed Chief Financial Officer at Merz North America

Thursday, June 21, 2018 | Business of Medicine , Personnel/Company News , Fillers & Injectables

Merz North America has appointed Alana Sine to Chief Financial Officer (CFO), Merz North America. Ms. Sine has served as interim CFO since March 2018.

Ms. Sine will lead the finance function for North America, overseeing financial reporting, governance, strategic planning, tax & treasury and collaboration with Merz’s global headquarters in Frankfurt, Germany, on financial matters. She will report to Bob Rhatigan, CEO of Merz North America and join the North America Leadership Team (NALT).

“Our exhaustive global search for a chief financial officer who can help us continue our rapid growth led us right back to Raleigh,” said Mr. Rhatigan. “Alana has a unique combination of deep industry experience and strong finance credentials. Her professionalism and effectiveness as interim CFO over the past four months made it clear that she’s the right person to help us achieve our goal of becoming the most admired, trusted and innovative aesthetics and neurotoxin company. As Merz continues to evolve and invest in talent development, we are proud to celebrate Alana’s career progression during her time with the company and look forward to her contributions and leadership in her new role as CFO.”

Over the course of her 13-year tenure at Merz North America, Ms. Sine assumed finance roles of increasing responsibility, including tax and financial reporting. As interim CFO, she successfully led the budget and strategic planning process for the coming fiscal year. Prior to joining Merz, she held accounting and finance roles at Ernst & Young (now EY) and Lowe’s Food Stores. She earned undergraduate and graduate degrees in accounting from the University of North Carolina-Greensboro and is a certified public accountant (CPA) in the state of North Carolina.

Next Story


You must be logged in to leave a comment.